Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?
Taysha Gene Therapies Ownership Summary
Taysha Gene Therapies is owned by 88.79% institutional investors, 11.04% insiders, and 0.17% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 8.17% of TSHA shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.16% of its assets in Taysha Gene Therapies shares.
TSHA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Taysha Gene Therapies | 88.79% | 11.04% | 0.17% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 24.35M | 8.17% | $79.64M |
| Ra capital management | 23.56M | 7.90% | $77.03M |
| Avoro capital advisors | 21.70M | 7.28% | $70.96M |
| Morgan stanley | 19.31M | 6.48% | $63.14M |
| Blackrock funding, inc. /de | 16.36M | 5.49% | $53.51M |
| Blackrock | 11.74M | 5.08% | $26.30M |
| Fmr | 14.59M | 4.90% | $47.72M |
| Goldman sachs group | 13.38M | 4.49% | $43.76M |
| Vanguard group | 12.85M | 4.31% | $42.02M |
| Siren | 11.01M | 3.70% | $36.02M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tybourne capital management (hk) | 3.70M | 39.11% | $12.10M |
| Octagon capital advisors lp | 9.07M | 4.49% | $29.65M |
| B group | 1.80M | 4.33% | $5.89M |
| Ally bridge group (ny) | 1.90M | 3.78% | $6.21M |
| Great point partners | 1.50M | 2.02% | $4.91M |
| Acuta capital partners | 454.83K | 1.54% | $1.49M |
| Siren | 11.01M | 1.41% | $36.02M |
| Rtw investments, lp | 24.35M | 0.98% | $79.64M |
| Ra capital management | 23.56M | 0.95% | $77.03M |
| Avoro capital advisors | 21.70M | 0.92% | $70.96M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 11.74M | 0.00% | 9.15M |
| Barclays | 5.15M | 0.00% | 4.70M |
| Blackrock funding, inc. /de | 16.36M | 0.00% | 3.06M |
| Affinity asset advisors | 3.00M | 0.85% | 2.80M |
| Vestal point capital, lp | 5.50M | 0.81% | 2.50M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jefferies financial group | 2.16M | 0.03% | -8.16M |
| Octagon capital advisors lp | 9.07M | 4.49% | -3.52M |
| Vr adviser | - | - | -3.23M |
| Suvretta capital management | - | - | -3.22M |
| Bioimpact capital | - | - | -2.95M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ally bridge group (ny) | 1.90M | 3.78% | 1.90M | $6.21M |
| Norges bank | 1.46M | 0.00% | 1.46M | $2.53M |
| Rice hall james & associates | 578.12K | 0.10% | 578.12K | $1.89M |
| Boothbay fund management | 415.61K | 0.02% | 415.61K | $1.36M |
| Dimensional fund advisors lp | 345.16K | 0.00% | 345.16K | $1.13M |
Sold Out
| Holder | Change |
|---|---|
| Quadrant capital group | -2.00 |
| National bank of canada /fi/ | -48.00 |
| Rothschild investment | -105.00 |
| Riggs asset managment | -198.00 |
| Coldstream capital management | -207.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 153 | 7.75% | 264,590,867 | 16.57% | 88 | 1.53% | 86 | -1.15% | 34 | 6.25% |
| Jun 30, 2025 | 148 | 16.54% | 257,619,957 | 54.48% | 86 | 2.25% | 90 | 45.16% | 33 | 10.00% |
| Mar 31, 2025 | 12 | -90.63% | 63,845,739 | -61.79% | 25 | 0.66% | 7 | -90.41% | 1 | -96.00% |
| Dec 31, 2024 | 126 | 5.00% | 167,074,710 | 6.47% | 62 | 1.82% | 72 | -4.00% | 25 | 56.25% |
| Sep 30, 2024 | 120 | 12.15% | 156,916,875 | -0.74% | 58 | 1.25% | 75 | 15.38% | 16 | -11.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 6.48M | 3.16% | - |
| Vanguard Total Stock Mkt Idx Inv | 6.63M | 2.43% | -147.09K |
| Vanguard US Total Market Shares ETF | 4.46M | 2.17% | - |
| Fidelity Growth Compy Commingled Pl S | 5.37M | 1.97% | 7.78K |
| Polar Capital Biotech S Inc | 5.00M | 1.83% | - |
| Fidelity Growth Company Fund | 4.21M | 1.54% | -25.17K |
| iShares Russell 2000 ETF | 4.03M | 1.48% | - |
| Fidelity Select Biotechnology | 3.46M | 1.27% | -53.10K |
| Xtrackers MSCI World Swap ETF 1C | 2.47M | 1.20% | - |
| Eagle Small Cap Core Inst'l | 1.26M | 0.62% | -298.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 01, 2025 | Nagendran Sukumar | President and Head of R&D | Sell | $1.17M |
| Nov 28, 2025 | Nagendran Sukumar | President and Head of R&D | Sell | $523.09K |
| Sep 10, 2025 | Nagendran Sukumar | President and Head of R&D | Sell | $646.00K |
| Aug 21, 2025 | Nagendran Sukumar | President and Head of R&D | Sell | $162.60K |
| Aug 21, 2025 | Alam Kamran | CHIEF FINANCIAL OFFICER | Sell | $155.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 2 |
| 2025 Q3 | - | 3 |
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | - |
| 2024 Q2 | 1 | - |
TSHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools